Epitope-based minigene vaccine targeting fibroblast activation protein α induces specific immune responses and anti-tumor effects in 4 T1 murine breast cancer model
Authors:
- 21 September 2022
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 112, 109237
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31300765)
- National Science and Technology Major Project (2014ZX09304314-001)
- Changchun Science and Technology Planning Project (17YJ002)
This publication has 49 references indexed in Scilit:
- The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatmentJournal of Translational Medicine, 2013
- An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platformOncoImmunology, 2012
- Myeloid derived suppressor cells in human diseasesInternational Immunopharmacology, 2011
- TAA Polyepitope DNA-Based Vaccines: A Potential Tool for Cancer TherapyJournal of Biomedicine and Biotechnology, 2010
- Immunoproteomics to identify tumor-associated antigens eliciting humoral responseCancer Letters, 2009
- The CD8+T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old VirusJournal of Virology, 2007
- Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptideBlood, 2006
- Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoproteinLeukemia, 2006
- A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virusNature Biotechnology, 2006
- Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular CarcinomaClinical Cancer Research, 2006